![](https://ibs.inc/wp-content/uploads/2024/05/INBS-Completes-Recruitment-for-FDA-510k-PK-Study-1.png)
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
NEW YORK, May 29, 2024 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company